Letter: extending FIT from DG30 to NG12 patients

Affiliations

Comment

James Turvill. Aliment Pharmacol Ther. 2020 Oct.

. 2020 Oct;52(8):1418.

doi: 10.1111/apt.16051.

No abstract available

Comment on

Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests.
Nicholson BD, James T, Paddon M, Justice S, Oke JL, East JE, Shine B. Nicholson BD, et al. Aliment Pharmacol Ther. 2020 Sep;52(6):1031-1041. doi: 10.1111/apt.15969. Epub 2020 Jul 17. Aliment Pharmacol Ther. 2020. PMID: 32677733
Letter: extending FIT from DG30 to NG12 patients. Letter: faecal immunochemical testing for adults with symptoms of colorectal cancer - ready for prime time? Authors' reply: a unified approach to safety netting negative FITs is required.
Nicholson BD, East JE, Oke J, Roberts NW, James T, Shine B. Nicholson BD, et al. Aliment Pharmacol Ther. 2020 Oct;52(8):1420-1421. doi: 10.1111/apt.16082. Aliment Pharmacol Ther. 2020. PMID: 33105974 No abstract available.
Letter: faecal immunochemical testing for adults with symptoms of colorectal cancer-ready for prime time?
Farrugia A, Widlak MM, Smith S, Waugh N, Arasaradnam RP. Farrugia A, et al. Aliment Pharmacol Ther. 2020 Oct;52(8):1419. doi: 10.1111/apt.16068. Aliment Pharmacol Ther. 2020. PMID: 33105978 No abstract available.

1. Nicholson BD, James T, Paddon M, et al. Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests. Aliment Pharmacol Ther. 2020;52:1031-1041.